# Janssen Pharmaceuticals, Inc.

Canonical: https://abierto.us/vendors/janssen-pharmaceuticals-inc-rdjszl3thv47

- UEI: RDJSZL3THV47
- CAGE: 78CR4
- Parent: Johnson & Johnson
- Location: Raritan, NJ
- Awards in window: 2 (3 transactions), -$392,446,395 obligated, August 8, 2024 to April 20, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, -$392,446,395

## Industries

- 541711 Professional, Scientific, and Technical Services: -$392,446,395

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- HHSO100201500014C: -$50,819,834, Barda - Aspr / Daappo / Barda DCMA. De-Obligation and Closeout of the Contract in Its Entirety.. https://www.usaspending.gov/award/CONT_IDV_HHSO100201500014C_7505/
- HHSO100201700018C: -$341,626,561, Barda - Aspr / Daappo / Barda DCMA. Janssen Influenza Portfolio and Other Emerging Pathogens Development Candidates. https://www.usaspending.gov/award/CONT_IDV_HHSO100201700018C_7505/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/janssen-pharmaceuticals-inc-rdjszl3thv47.